NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks The National Institute for Care and Excellence (NICE) has announced that it has recommended an oral treatment for the prevention of episodic migraines for the first time...

Five things for pharma marketers to know: The Centers for Medicare and Medicaid Services announced plans to broadly cover a new class of Alzheimer’s drugs pending approval by the Food and Drug Administration.  Sandoz said it plans to move to a...

Objective Platfom is derde partner Nationale Marketing Benchmark Objective Platform gaat als derde partner deelnemen aan de Nationale Marketing Benchmark, naast initiatiefnemer Mark Stronger en bestaande partner SRM Opleidingen en Trainingen. De...